Business Wire

Health Canada Grants License for Quidel® TriageTrue® High-Sensitivity Troponin I Test to Aid in the Diagnosis of Myocardial Infarction

SAN DIEGO--(BUSINESS WIRE)--QuidelOrtho Corporation (Nasdaq: QDEL) (“QuidelOrtho”), a global provider of innovative in vitro diagnostic technologies designed for point-of-care settings, clinical labs ...
Nasdaq

QuidelOrtho's (QDEL) Myocardial Infarction Test Cleared in Canada

QuidelOrtho Corporation QDEL recently announced that its TriageTrue High-Sensitivity Troponin I (hsTnl) Test on the Quidel Triage MeterPro had been approved for use in Canada by Health Canada. Per the ...
FierceBiotech

QuidelOrtho's recall of potentially faulty heart attack blood tests lands FDA Class I tag

QuidelOrtho is recalling thousands of blood tests used to help quickly diagnose myocardial infarctions and other heart conditions. The company began recalling certain lots of the Quidel Triage Cardiac ...
Becker's Hospital Review

Cardiac panel tests recalled for risk of missed heart attacks

Nearly 8,000 cardiac panel blood tests have been recalled after 41 reports of inaccurate test results that pose the risk of missing a heart attack diagnosis, the FDA said July 17. Quidel ...